Vivos Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $3,824 | $3,824 | $6,783 | $3,820 |
Gross Profit | 2,988 | 2,988 | 3,937 | 2,110 |
EBITDA | -5,940 | -4,350 | -4,559 | |
EBIT | -6,382 | -4,734 | -4,865 | |
Net Income | -6,954 | -6,954 | -5,400 | -5,013 |
Net Change In Cash | 3,824 | 3,824 | 6,783 | 3,820 |
Free Cash Flow | -4,705 | -5,343 | -3,268 | -4,265 |
Cash | 2,029 | 2,029 | 3,087 | 4,402 |
Basic Shares | 9,286 | 9,286 | 10,963 | 9,087 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $17,443 | $15,031 | $13,801 | $16,024 |
Gross Profit | 10,542 | 9,019 | 8,271 | 10,019 |
EBITDA | -18,585 | -10,590 | -16,675 | -24,362 |
EBIT | -19,894 | -11,171 | -17,296 | -25,031 |
Net Income | -21,230 | -11,136 | -13,583 | -23,845 |
Net Change In Cash | 17,443 | 15,031 | 13,801 | 16,024 |
Free Cash Flow | -17,604 | -13,259 | -12,749 | -20,511 |
Cash | 2,029 | 6,260 | 1,643 | 3,519 |
Basic Shares | 10,273 | 5,019 | 1,219 | 920 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.58 |
2025-09-30 | -$0.49 |
2025-06-30 | -$0.55 |